Accurate ultrasonography-based portal pressure assessment in patients with hepatocellular carcinoma

Table 1 Characteristics of the included patients, n = 102

Index		Index
Age (yr)	54 ± 13	Globulin (g/dL)	30.5 ± 8.9
Gender (male/female)	65/37	Albumin (g/dL)	34.9 ± 5.9
Etiology, n	102	Total protein (g/dL)	65.5 ± 10.0
Virus	48	ALP (U/L)	120.6 ± 86.7
Alcohol	20	GGT (U/L)	67.7 ± 82.3
Cryptogenic	5	BUN (mmol/L)	6.8 ± 5.4
Multifactorial	20	Creatinine (μmol/L)	88.7 ± 138.6
Others	9	LDH (UL)	194.3 ± 59.8
GB history, n (%)	76 (74.51)	K (mmol/L)	4.0 ± 0.7
Refractory ascites, n (%)	78 (76.47)	Na (mmol/L)	138.4 ± 14.5
Encephalopathy, n (%)	4 (3.92)	Cl (mmol/L)	106.4 ± 5.1
Red blood cells (1012/L)	3.3 ± 1.6	Ca (mmol/L)	2.15 ± 0.15
Hemoglobin (g/L)	91.6 ± 25.3	Blood ammonia (μmol/L)	51.2 ± 30.0
White blood cells (1012/L)	4.1 ± 4.0	FIB (n/L)	2.3 ± 1.5
Platelet count (109/L)	106.7 ± 95.7	APTT (s)	34.5 ± 6.3
ALT (U/L)	24.4 ± 18.0	TT (s)	17.7 ± 5.4
AST (U/L)	35.0 ± 24.4	D dimer level (μg/L)	809 ± 1009
TBIL (mg/dL)	2.20 ± 3.61	Child–Pugh class, n (A/B/C)	26/58/18
DBIL (mg/dL)	1.41 ± 3.14	ALBI score	-2.06 ± 0.47
IBIL (mg/dL)	0.67 ± 0.43	MELD score	7.66 ± 5.46
PT(s)	14.6 ± 3.6	HVPG (mmHg)	17.07 ± 4.78
PT (%)	61.1 ± 16.6	PVP (mmHg)	34.40 ± 5.95
INR	1.4 ± 0.3	PPG (mmHg)	17.32 ± 1.97

GB: Gastrointestinal bleeding; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; PT: Prothrombin time; TBIL: Total bilirubin; INR: International normalized ratio; ALP: Alkaline phosphatase; GGT: Glutamyl transpeptidase; BUN: Blood urea nitrogen; LDH: Lactate dehydrogenase; APTT: Activated partial thromboplastin time; TT: Thrombin time; HVPG: Hepatic venous pressure gradient; PVP: Portal vein pressure; PPG: Portal pressure gradient.